Mark D Kilby Selected Research

Fetal Therapies (Fetal Therapy)

1/2021	Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
1/2020	Red cell alloimmunization: A 2020 update.
1/2018	Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
1/2014	Fetal therapy for the treatment of congenital bladder neck obstruction.
10/2009	A review of the methodological features of systematic reviews in fetal medicine.
6/2005	Contemporary treatments for twin-twin transfusion syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark D Kilby Research Topics

Disease

11	Fetofetal Transfusion (Twin Transfusion Syndrome) 01/2022 - 06/2005
8	Premature Birth (Birth, Premature) 01/2022 - 05/2011
7	Pre-Eclampsia (Preeclampsia) 01/2022 - 02/2005
6	Anemia 01/2021 - 01/2015
5	Spontaneous Abortion (Miscarriage) 01/2021 - 05/2011
4	Birth Weight (Birth Weights) 01/2022 - 03/2017
4	Neoplasms (Cancer) 01/2022 - 09/2004
3	Proteinuria 10/2021 - 02/2003
3	Hypertension (High Blood Pressure) 10/2021 - 04/2005
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2021 - 06/2007
3	Stillbirth 01/2021 - 12/2013
3	Hydrops Fetalis (Fetal Edema) 01/2021 - 01/2015
3	Polycythemia (Erythrocytosis) 01/2021 - 01/2020
3	Aneuploidy (Aneuploid) 01/2020 - 10/2009
3	Fetal Death 01/2019 - 01/2018
2	Postpartum Hemorrhage 11/2021 - 01/2020
2	Vitamin D Deficiency 04/2021 - 01/2018
2	Perinatal Death 01/2021 - 01/2014
2	Habitual Abortion (Recurrent Miscarriage) 11/2015 - 03/2014
1	Sepsis (Septicemia) 01/2021
1	Enterocolitis 01/2021
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021
1	Hyperglycemia 01/2021
1	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 01/2021
1	Abnormal Karyotype 01/2020
1	Vascular Remodeling 01/2020
1	Fistula 01/2020
1	Trisomy (Trisomies) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Infertility (Sterility) 01/2019
1	Hemolysis 01/2018
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Necrosis 01/2014
1	Ischemia 12/2013
1	Hypothyroidism 12/2013

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2018
4	Vitamin D FDA LinkGeneric 04/2021 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2007
3	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019 - 05/2011
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2016
2	hydroxide ionIBA 04/2021 - 01/2020
2	CytokinesIBA 01/2021 - 01/2014
2	Cell-Free Nucleic AcidsIBA 01/2020 - 12/2019
2	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 07/2017 - 03/2017
2	AlbuminsIBA 05/2017 - 02/2003
2	Progesterone FDA LinkGeneric 11/2015 - 08/2006
2	Messenger RNA (mRNA)IBA 10/2012 - 09/2004
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	LipidsIBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021
1	mitoquinoneIBA 10/2021
1	AntioxidantsIBA 10/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	G-Protein-Coupled Receptor KinasesIBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2021
1	EphrinsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	N 30IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	dichlorobis(azomycin)platinum IIIBA 12/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Iodide Peroxidase (Deiodinase)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	CreatinineIBA 05/2017
1	CarbohydratesIBA 01/2016
1	Suppositories (Vaginal Suppositories)IBA 11/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 02/2014
1	InterleukinsIBA 01/2014
1	InterferonsIBA 01/2014
1	Interleukin-4 (Interleukin 4)IBA 01/2014
1	Interleukin-8 (Interleukin 8)IBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2014
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2014

Therapy/Procedure

6	Fetal Therapies (Fetal Therapy) 01/2021 - 06/2005
3	Laser Coagulation 01/2022 - 01/2014
3	Pessaries 01/2021 - 12/2018
3	Lasers (Laser) 06/2020 - 06/2005
2	Laser Therapy (Surgery, Laser) 01/2021 - 01/2009
1	Drug Therapy (Chemotherapy) 01/2022
1	Cardiopulmonary Resuscitation (CPR) 01/2020
1	Prenatal Care (Care, Prenatal) 01/2020
1	Hysterectomy 01/2020
1	Analgesia 01/2020
1	Intrauterine Blood Transfusion 01/2018
1	Therapeutics 11/2015
1	Punctures 01/2015
1	Immunomodulation 03/2014
1	Transplantation 01/2014
1	Conservative Treatment 01/2014